These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22388757)

  • 21. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
    Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
    Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
    Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
    Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
    Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
    BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer.
    Vieira AF; Ricardo S; Ablett MP; Dionísio MR; Mendes N; Albergaria A; Farnie G; Gerhard R; Cameselle-Teijeiro JF; Seruca R; Schmitt F; Clarke RB; Paredes J
    Stem Cells; 2012 May; 30(5):854-64. PubMed ID: 22389315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.
    Hwang-Verslues WW; Kuo WH; Chang PH; Pan CC; Wang HH; Tsai ST; Jeng YM; Shew JY; Kung JT; Chen CH; Lee EY; Chang KJ; Lee WH
    PLoS One; 2009 Dec; 4(12):e8377. PubMed ID: 20027313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
    Park SY; Lee HE; Li H; Shipitsin M; Gelman R; Polyak K
    Clin Cancer Res; 2010 Feb; 16(3):876-87. PubMed ID: 20103682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.
    Creighton CJ; Li X; Landis M; Dixon JM; Neumeister VM; Sjolund A; Rimm DL; Wong H; Rodriguez A; Herschkowitz JI; Fan C; Zhang X; He X; Pavlick A; Gutierrez MC; Renshaw L; Larionov AA; Faratian D; Hilsenbeck SG; Perou CM; Lewis MT; Rosen JM; Chang JC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13820-5. PubMed ID: 19666588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.
    Giatromanolaki A; Sivridis E; Fiska A; Koukourakis MI
    Med Oncol; 2011 Sep; 28(3):745-52. PubMed ID: 20405247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
    Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
    Nakshatri H; Srour EF; Badve S
    Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma.
    Lin Y; Zhong Y; Guan H; Zhang X; Sun Q
    J Exp Clin Cancer Res; 2012 Jul; 31(1):59. PubMed ID: 22762532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.
    Bane A; Viloria-Petit A; Pinnaduwage D; Mulligan AM; O'Malley FP; Andrulis IL
    Breast Cancer Res Treat; 2013 Jul; 140(1):195-205. PubMed ID: 23813303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis.
    Wei W; Hu H; Tan H; Chow LW; Yip AY; Loo WT
    J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S6. PubMed ID: 23046710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGFβ1 Promotes Breast Cancer Local Invasion and Liver Metastasis by Increasing the CD44
    Zhang C; Gao H; Li C; Tu J; Chen Z; Su W; Geng X; Chen X; Wang J; Pan W
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818764497. PubMed ID: 29658391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice.
    Vieira AF; Dionísio MR; Gomes M; Cameselle-Teijeiro JF; Lacerda M; Amendoeira I; Schmitt F; Paredes J
    Mod Pathol; 2017 May; 30(5):698-709. PubMed ID: 28084338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer.
    Ding J; Jin W; Chen C; Shao Z; Wu J
    PLoS One; 2012; 7(7):e41942. PubMed ID: 22848668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.